ROBERT WEINSTEIN, MD
Osteopathic Medicine at Lake Ave, Worcester, MA
License number
Massachusetts 42730
Category
Medical Practice
Type
Blood Banking & Transfusion Medicine
License number
Massachusetts 42730
Category
Osteopathic Medicine
Type
Hematology
Address
Address
2
55 Lake Ave N, Worcester, MA 01655
PO Box 415348, Boston, MA 02241
PO Box 415348, Boston, MA 02241
Phone
(508) 334-3725
(508) 334-7939 (Fax)
(508) 334-7939 (Fax)
Personal information
See more information about ROBERT WEINSTEIN at radaris.comName
Address
Phone
45 Highland Ave #2, Winthrop, MA 02152
60 Louis St, Brockton, MA 02302
87 Allen Ave, Waban, MA 02468
7 Atherton Ln, Sharon, MA 02067
7 Janine Dr, North Easton, MA 02356
Organization information
See more information about ROBERT WEINSTEIN at bizstanding.comROBERT WEINSTEIN, PC
101 Arch St, Boston, MA 02110
Status:
Inactive
Registration:
Oct 16, 1986
Inactive since:
Aug 31, 1998
State ID:
042935518
Business type:
Professional Corporation
President:
Robert Weinstein (President), 527 Commonwealth Ave, Boston, MA 02110 (Physical)
Professional information
M At Mystic Medical Group He Has A The 4 Weeks Adjust The Coumadin Has Not Had A Cholesterol Now We Do Th
Position:
M at Mystic Medical Group he has a the 4 weeks adjust the Coumadin has not had a cholesterol now we do th, community MD at Partners Community Healthcare
Location:
Greater Boston Area
Industry:
Hospital & Health Care
Work:
Mystic Medical Group he has a the 4 weeks adjust the Coumadin has not had a cholesterol now we do th
-
M
Partners Community Healthcare
since 2003
-
community MD
Dr. Robert Weinstein, Boston MA - MD (Doctor of Medicine)
Specialties:
Internal Medicine, Allergy & Immunology
Address:
177 Commonwealth Ave, Boston 02116
(617) 247-0010 (Phone)
22250 Providence Dr SUITE 204, Southfield 48075
(617) 247-0010 (Phone)
22250 Providence Dr SUITE 204, Southfield 48075
Certifications:
Allergy & Immunology, 1975, Internal Medicine, 1972
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Tufts University
Maimonides Hosp
Henry Ford Hospital
Tufts University
Maimonides Hosp
Henry Ford Hospital
Method And Device For Facilitating Combined Aerosol And Oral Treatments For Diabetes Mellitus
US Patent:
6447751, Sep 10, 2002
Filed:
Apr 18, 2001
Appl. No.:
09/837723
Inventors:
Robert E. Weinstein - Boston MA 02116
Allan M. Weinstein - Potomac MD 20854
Allan M. Weinstein - Potomac MD 20854
International Classification:
A61K 912
US Classification:
424 45, 424 46, 424464, 424400
Abstract:
A dispensing container which incorporates an aerosolizable topical insulin preparation, at least one oral hypoglycemic agent, and indicia and instructions for their coordinated use as a single therapeutic regimen for the treatment of diabetes mellitus in a human, and a method for treating diabetes mellitus which employs such a device.
Method And Device For Organizing And Coordinating The Combined Use Of Topical Aerosols For The Treatment Of Respiratory Disorders
US Patent:
5941241, Aug 24, 1999
Filed:
May 12, 1997
Appl. No.:
8/855893
Inventors:
Robert E. Weinstein - Boston MA
Allan M. Weinstein - Potomac MD
Allan M. Weinstein - Potomac MD
International Classification:
A61M 1100, B65D 8304, G09F 300
US Classification:
12820023
Abstract:
A method and device for organizing, storing, instructing, and coordinating the combined use of aerosol medications for the treatment of disorders including respiratory tract disorders for the purpose of reducing medication error and increasing therapeutic compliance.
Method Of Preventing The Effects Of Altered .Delta.-5 Pathway Steroidogenesis In Adrenergically Blockaded Conditions
US Patent:
6297288, Oct 2, 2001
Filed:
Jan 10, 1997
Appl. No.:
8/781828
Inventors:
Robert E. Weinstein - Boston MA
International Classification:
A61K 31135
US Classification:
514653
Abstract:
The production of sex steroids by the. DELTA. -5 steroidogenic pathway has been found to be under control of the adrenergic nervous system, and sex steroids produced by this pathway are diminished in individuals with adrenergically-blockaded conditions. This invention relates to diminishing the consequences of suppressed. DELTA. -5 pathway steroidogenesis in individuals with adrenergically blockaded conditions by the administration of compositions which raise the serum levels of sex steroids.
Dosage Unit For Cardioprotection
US Patent:
2007023, Oct 11, 2007
Filed:
May 14, 2007
Appl. No.:
11/748061
Inventors:
Herbert Dean - Waban MA, US
Robert Weinstein - Boston MA, US
Allan Weinstein - Potomac MD, US
Robert Weinstein - Boston MA, US
Allan Weinstein - Potomac MD, US
International Classification:
A61K 31/44, A61K 31/50, A61K 31/70, A61P 9/04
US Classification:
514052000, 514249000, 514347000
Abstract:
A method for secondary cardiovascular prevention in a patient includes formulating a single dosage unit containing a beta-adrenergic blocking agent and a cholesterol-lowering agent that is a statin where the single dosage unit contains a quantity of medications sufficient for secondary prevention of a heart attack in the patient, and administering the single dosage unit to the patient for secondary prevention of a heart attack. The method further includes the secondary prevention of a heart attack in a non-hypertensive patient.
Antihistamine/Decongestant Regimens For Treating Rhinitis
US Patent:
6843372, Jan 18, 2005
Filed:
Aug 18, 2003
Appl. No.:
10/642718
Inventors:
Robert E. Weinstein - Boston MA, US
International Classification:
B65D 8304
US Classification:
206534, 206538
Abstract:
A prepackaged, therapeutic regimen includes a non-sedating first dosage unit that includes a nasal decongestant, a second dosage unit that includes an antihistamine and an attenuated dosage of nasal decongestant, indicia for distinguishing between the first and second dosage units, administration instructions that teach the coordinated use of the first and second dosage units, and a pharmaceutical dispensing container containing the first and second dosage units and incorporating the indicia and coordinating instructions.
Liquid Drinking Assemblage And System
US Patent:
5806765, Sep 15, 1998
Filed:
Sep 11, 1996
Appl. No.:
8/712460
Inventors:
Robert E. Weinstein - Boston MA
International Classification:
A47G 2118
US Classification:
239 33
Abstract:
An assemblage and system for drinking a plurality of potable and/or medicinal liquids simultaneously from discrete receptacles. The assemblage comprises a plurality of conduits joined together that convey isolated streams of the liquids from separate receptacles into the mouth. The cross-sectional area of the conduits regulate the amount of each liquid reaching the mouth and may be dynamically controlled. Preferably, the conduits are mechanically deformable along their axes of elongation. Preferably, the conduits are joined together near the end of the conduits that enter the mouth. The conduits are joined by a catch, by binding, or by molding the conduits as a single unit. The system includes the assemblage and a number of isolated receptacles.
Method And Device For Coordinating Topical And Oral Sinusitis Treatments
US Patent:
6294178, Sep 25, 2001
Filed:
Nov 1, 1999
Appl. No.:
9/431806
Inventors:
Robert E. Weinstein - Boston MA
Allan M. Weinstein - Potomac MD
Allan M. Weinstein - Potomac MD
International Classification:
A61K 900, A61K 948, A61K 920, A61K 914, A61L 904
US Classification:
424400
Abstract:
A sinusitis treatment system having an oral dosage constituent, a topical nasal dosage constituent, indicia and instructions for administration of the oral dosage constituent and the topical nasal dosage constituent as an at least ten-day sinusitis treatment regimen.
Device For Delivering Aerosol To The Nasal Membranes And Method Of Use
US Patent:
5437267, Aug 1, 1995
Filed:
Aug 3, 1993
Appl. No.:
8/101328
Inventors:
Allan Weinstein - Potomac MD
Robert Weinstein - Boston MA
Robert Weinstein - Boston MA
International Classification:
A61M 1100, A61M 1508, A61M 1610, A62B 700
US Classification:
12820023
Abstract:
A device for the intranasal delivery of a medicament regimen to the nasal membranes for the treatment of such conditions as rhinitis.